By Jamie Oliver
Peer Reviewed
“Hold metformin, start sliding-scale insulin, diabetic diet, subcutaneous heparin.”
Just 10 words. For almost all admitted type 2 diabetics receiving metformin, this 10-word phrase is automatic. I am sure many …
Category: Class Act
Clinical Correlations
What Is The Role Of Serologic Testing For Immunity To Measles During An Outbreak?
September 18, 2019
By Sandra Goldlust
Peer Reviewed
Measles was declared eliminated from the US in 2000. Our country, however, is currently in the midst of the largest measles outbreak since 1992. …
Sodium Retention and Edema in Nephrotic Syndrome: New Models and Therapeutic Targets
July 23, 2019
By Maria Smith
Peer Reviewed
The mechanism of sodium retention and edema formation in patients with nephrotic syndrome has long been highly contested in the nephrology world. The traditional teaching was that proteinuria …
One Diet Does Not Fit All
July 18, 2019
By Ashira Lubkin, PhD
Peer Reviewed
For me, one of the most difficult things to do in outpatient medicine is to tell a patient that they need to lose …
Is There Evidence to Support the Use of Omega-3 Fatty Acids in Preventing Cardiovascular Events?
May 24, 2019
By Lily Cao
Peer Reviewed
A quick web search would suggest countless reasons to take fish oil, a supplement that Americans have fallen in love with. In 2012, fish …
Does Wearable Technology Improve Physical Activity?
April 23, 2019
By David Ruohoniemi
Peer Reviewed
The obesity epidemic has been widely reported in recent years. In 2005, an estimated 23.2% of the world’s population was overweight and 9.8% were …
Are Opioids Effective in the Treatment of Chronic Low Back Pain?
April 17, 2019
By Anna Hirsch
Peer Reviewed
The use of opioid medications for chronic low back pain, or for any chronic non-cancer pain complaint, is still a source of …
Is There a Role for DOAC Level Monitoring in Clinical Practice?
April 9, 2019
By Thatcher Heumann, MD
Peer Reviewed
Background
Direct Oral Anticoagulants (DOACs) are a class of medications consisting of the thrombin inhibitor, dabigatran (Pradaxa), and the factor Xa inhibitors, rivaroxaban (Xarelto), apixaban (Eliquis), …